Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes

  1. Bethel, M.A.
  2. Stevens, S.R.
  3. Buse, J.B.
  4. Choi, J.
  5. Gustavson, S.M.
  6. Iqbal, N.
  7. Lokhnygina, Y.
  8. Mentz, R.J.
  9. Patel, R.A.
  10. Öhman, P.
  11. Schernthaner, G.
  12. Lecube, A.
  13. Hernandez, A.F.
  14. Holman, R.R.
Revue:
Circulation

ISSN: 1524-4539,  0009-7322

Année de publication: 2020

Volumen: 141

Número: 17

Pages: 1360-1370

Type: Article

DOI: 10.1161/CIRCULATIONAHA.119.043353 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objetivos de desarrollo sostenible

La source de données: Scopus